These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

975 related articles for article (PubMed ID: 21324198)

  • 1. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients.
    Koch A; Voigt S; Kruschinski C; Sanson E; Dückers H; Horn A; Yagmur E; Zimmermann H; Trautwein C; Tacke F
    Crit Care; 2011; 15(1):R63. PubMed ID: 21324198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble urokinase-type plasminogen activator receptor as a prognostic biomarker in critically ill patients.
    Donadello K; Scolletta S; Taccone FS; Covajes C; Santonocito C; Cortes DO; Grazulyte D; Gottin L; Vincent JL
    J Crit Care; 2014 Feb; 29(1):144-9. PubMed ID: 24120089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of circulating amino-terminal pro-C-type natriuretic peptide in critically ill patients.
    Koch A; Voigt S; Sanson E; Dückers H; Horn A; Zimmermann HW; Trautwein C; Tacke F
    Crit Care; 2011; 15(1):R45. PubMed ID: 21281508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble Urokinase Plasminogen Activator Receptor: A New Biomarker in the Pediatric Intensive Care Unit.
    El-Mekkawy MS; Saleh NY; Sonbol AA
    Indian J Pediatr; 2016 Jul; 83(7):661-9. PubMed ID: 26960717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive value of soluble urokinase plasminogen activator receptor (SuPAR) regarding 90-day mortality and 12-month neurological outcome in critically ill patients after out-of-hospital cardiac arrest. Data from the prospective FINNRESUSCI study.
    Jalkanen V; Vaahersalo J; Pettilä V; Kurola J; Varpula T; Tiainen M; Huhtala H; Alaspää A; Hovilehto S; Kiviniemi O; Kuitunen A; Tenhunen J;
    Resuscitation; 2014 Nov; 85(11):1562-7. PubMed ID: 25193800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophils are a main source of circulating suPAR predicting outcome in critical illness.
    Gussen H; Hohlstein P; Bartneck M; Warzecha KT; Buendgens L; Luedde T; Trautwein C; Koch A; Tacke F
    J Intensive Care; 2019; 7():26. PubMed ID: 31061709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission.
    Suberviola B; Castellanos-Ortega A; Ruiz Ruiz A; Lopez-Hoyos M; Santibañez M
    Intensive Care Med; 2013 Nov; 39(11):1945-52. PubMed ID: 23949703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble urokinase plasminogen activator receptor (suPAR) predicts critical illness and kidney failure in patients admitted to the intensive care unit.
    Reisinger AC; Niedrist T; Posch F; Hatzl S; Hackl G; Prattes J; Schilcher G; Meißl AM; Raggam RB; Herrmann M; Eller P
    Sci Rep; 2021 Sep; 11(1):17476. PubMed ID: 34471146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can soluble urokinase plasminogen receptor predict outcomes after cardiac surgery?
    Schultz-Swarthfigure CT; McCall P; Docking R; Galley HF; Shelley B
    Interact Cardiovasc Thorac Surg; 2021 Jan; 32(2):236-243. PubMed ID: 33236082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients.
    Koch A; Gressner OA; Sanson E; Tacke F; Trautwein C
    Crit Care; 2009; 13(3):R95. PubMed ID: 19545363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis.
    Zimmermann HW; Koch A; Seidler S; Trautwein C; Tacke F
    Liver Int; 2012 Mar; 32(3):500-9. PubMed ID: 22098627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. suPAR as a marker of infection in acute kidney injury - a prospective observational study.
    Hall A; Crichton S; Varrier M; Bear DE; Ostermann M
    BMC Nephrol; 2018 Aug; 19(1):191. PubMed ID: 30071826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review.
    Backes Y; van der Sluijs KF; Mackie DP; Tacke F; Koch A; Tenhunen JJ; Schultz MJ
    Intensive Care Med; 2012 Sep; 38(9):1418-28. PubMed ID: 22706919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating retinol binding protein 4 in critically ill patients before specific treatment: prognostic impact and correlation with organ function, metabolism and inflammation.
    Koch A; Weiskirchen R; Sanson E; Zimmermann HW; Voigt S; Dückers H; Trautwein C; Tacke F
    Crit Care; 2010; 14(5):R179. PubMed ID: 20932285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation and prognostic relevance of serum ghrelin concentrations in critical illness and sepsis.
    Koch A; Sanson E; Helm A; Voigt S; Trautwein C; Tacke F
    Crit Care; 2010; 14(3):R94. PubMed ID: 20500817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombocytopenia in critically ill patients with severe sepsis/septic shock: Prognostic value and association with a distinct serum cytokine profile.
    Tsirigotis P; Chondropoulos S; Frantzeskaki F; Stamouli M; Gkirkas K; Bartzeliotou A; Papanikolaou N; Atta M; Papassotiriou I; Dimitriadis G; Dimopoulou I
    J Crit Care; 2016 Apr; 32():9-15. PubMed ID: 26726794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of APACHE II score and plasma suPAR in Chinese patients with sepsis: a prospective observational study.
    Liu X; Shen Y; Li Z; Fei A; Wang H; Ge Q; Pan S
    BMC Anesthesiol; 2016 Jul; 16(1):46. PubMed ID: 27473112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated asymmetric dimethylarginine levels predict short- and long-term mortality risk in critically ill patients.
    Koch A; Weiskirchen R; Kunze J; Dückers H; Bruensing J; Buendgens L; Matthes M; Luedde T; Trautwein C; Tacke F
    J Crit Care; 2013 Dec; 28(6):947-53. PubMed ID: 23953490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study.
    Rasmussen LJ; Ladelund S; Haupt TH; Ellekilde G; Poulsen JH; Iversen K; Eugen-Olsen J; Andersen O
    Emerg Med J; 2016 Nov; 33(11):769-775. PubMed ID: 27590986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could soluble urokinase plasminogen receptor (suPAR) be used as a diagnostic biomarker for ventilator-associated pneumonia?
    Sunnetcioglu A; Sunnetcioglu M; Adıyaman F; Binici I; Soyoral L
    Clin Respir J; 2017 Nov; 11(6):925-930. PubMed ID: 26683264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.